Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease
Corresponding Author
Meena Thayu MD
Children's Hospital of Philadelphia–Gastroenterology, Hepatology, and Nutrition, Philadelphia Pennsylvania
Children's Hospital of Philadelphia–Gastroenterology, Hepatology, and Nutrition, 3535 Market Street, Philadelphia PA 19104Search for more papers by this authorJustine Shults PhD
Children's Hospital of Philadelphia–Gastroenterology, Hepatology, and Nutrition, Philadelphia Pennsylvania
Search for more papers by this authorJon M. Burnham MD, MSCE
Children's Hospital of Philadelphia–Gastroenterology, Hepatology, and Nutrition, Philadelphia Pennsylvania
Search for more papers by this authorBabette S. Zemel PhD
Children's Hospital of Philadelphia–Gastroenterology, Hepatology, and Nutrition, Philadelphia Pennsylvania
Search for more papers by this authorRobert N. Baldassano MD
Children's Hospital of Philadelphia–Gastroenterology, Hepatology, and Nutrition, Philadelphia Pennsylvania
Search for more papers by this authorMary B. Leonard MD, MSCE
Children's Hospital of Philadelphia–Gastroenterology, Hepatology, and Nutrition, Philadelphia Pennsylvania
Search for more papers by this authorCorresponding Author
Meena Thayu MD
Children's Hospital of Philadelphia–Gastroenterology, Hepatology, and Nutrition, Philadelphia Pennsylvania
Children's Hospital of Philadelphia–Gastroenterology, Hepatology, and Nutrition, 3535 Market Street, Philadelphia PA 19104Search for more papers by this authorJustine Shults PhD
Children's Hospital of Philadelphia–Gastroenterology, Hepatology, and Nutrition, Philadelphia Pennsylvania
Search for more papers by this authorJon M. Burnham MD, MSCE
Children's Hospital of Philadelphia–Gastroenterology, Hepatology, and Nutrition, Philadelphia Pennsylvania
Search for more papers by this authorBabette S. Zemel PhD
Children's Hospital of Philadelphia–Gastroenterology, Hepatology, and Nutrition, Philadelphia Pennsylvania
Search for more papers by this authorRobert N. Baldassano MD
Children's Hospital of Philadelphia–Gastroenterology, Hepatology, and Nutrition, Philadelphia Pennsylvania
Search for more papers by this authorMary B. Leonard MD, MSCE
Children's Hospital of Philadelphia–Gastroenterology, Hepatology, and Nutrition, Philadelphia Pennsylvania
Search for more papers by this authorAbstract
Background: Childhood Crohn's disease (CD) is associated with poor growth and decreased body mass index (BMI); however, lean mass (LM) and fat mass (FM) deficits prior to therapy have not been characterized.
Objectives: To quantify LM and FM in incident pediatric CD subjects and controls, and to identify determinants of LM and FM deficits.
Methods: Whole body LM and FM were assessed using DXA in 78 CD subjects and 669 healthy controls, ages 5-21 yr. Gender specific z-scores for LM (LM-Ht) and FM (FM-Ht) relative to height were derived using log linear regression models in the controls. Multivariate linear regression models adjusted for potential confounders.
Results: CD was associated with significantly lower height and BMI for age. Within CD subjects, FM-Ht and LM-Ht were significantly lower in females compared with males (FM-Ht z: −0.66 ± 0.83 vs. −0.08 ± 0.95, p < 0.01; LM-Ht z: −1.12 ± 1.12 vs. −0.57 ± 0.99, p < 0.05). In females, CD was associated with significantly lower LM-Ht (p < 0.001) and FM-Ht (p = 0.001), adjusted for age, race and Tanner stage, compared with controls. LM and FM deficits were significantly greater in older females with CD; 47% of adolescent females had LM-Ht ≤ 5th percentile. In non-black males, CD was also associated with lower LM-Ht (p < 0.02); FM-Ht deficits were not significant.
Conclusions: Incident CD was associated with significant LM deficits in males and females, and FM deficits in females. Future studies are needed to identify etiologies for the age and gender differences and to evaluate therapies for these deficits.
(Inflamm Bowel Dis 2007)
REFERENCES
- 1 Ellis KJ. Human body composition: in vivo methods. Physiol Rev. 2000; 80: 649–680.
- 2 Bechard L, Puig M. Body composition and growth. In: W Walker, J Watkins, C Duggan, eds. Nutrition in pediatrics. London: BC Decker; 2003: 32–51.
- 3 Roubenoff R, Kehayias JJ. The meaning and measurement of lean body mass. Nutr Rev. 1991; 49: 163–175.
- 4 Schonau E, Werhahn E, Schiedermaier U, et al. Influence of muscle strength on bone strength during childhood and adolescence. Horm Res. 1996; 45(Suppl 1): 63–66.
- 5 Burnham JM, Shults J, Semeao E, et al. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res. 2004; 19: 1961–1968.
- 6 Boot AM, Bouquet J, Krenning EP, et al. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut. 1998; 42: 188–194.
- 7 Capristo E, Addolorato G, Mingrone G, et al. Effect of disease localization on the anthropometric and metabolic features of Crohn's disease. Am J Gastroenterol. 1998; 93: 2411–2419.
- 8 Capristo E, Mingrone G, Addolorato G, et al. Metabolic features of inflammatory bowel disease in a remission phase of the disease activity. J Intern Med. 1998; 243: 339–347.
- 9 Mingrone G, Benedetti G, Capristo E, et al. Twenty-four-hour energy balance in Crohn disease patients: metabolic implications of steroid treatment. Am J Clin Nutr. 1998; 67: 118–123.
- 10 Haderslev KV, Jeppesen PB, Sorensen HA, et al. Body composition measured by dual-energy X-ray absorptiometry in patients who have undergone small-intestinal resection. Am J Clin Nutr. 2003; 78: 78–83.
- 11 Azcue M, Rashid M, Griffiths A, et al. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Gut. 1997; 41: 203–208.
- 12 Jahnsen J, Falch JA, Mowinckel P, et al. Body composition in patients with inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2003; 98: 1556–1562.
- 13 Geerling BJ, Lichtenbelt WD, Stockbrugger RW, et al. Gender specific alterations of body composition in patients with inflammatory bowel disease compared with controls. Eur J Clin Nutr. 1999; 53: 479–485.
- 14 Schneeweiss B, Lochs H, Zauner C, et al. Energy and substrate metabolism in patients with active Crohn's disease. J Nutr. 1999; 129: 844–848.
- 15 Burnham JM, Shults J, Semeao E, et al. Body-composition alterations consistent with cachexia in children and young adults with Crohn disease. Am J Clin Nutr. 2005; 82: 413–420.
- 16 Roubenoff R, Roubenoff RA, Ward LM, et al. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol. 1992; 19: 1505–1510.
- 17 Rall LC, Roubenoff R. Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology (Oxf). 2004; 43: 1219–1223.
- 18 Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991; 12: 439–447.
- 19 Morris NN, Udry JR. Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc. 1980: 271–280.
- 20 Tanner JM. Growth at adolescence. London: Blackwell Scientific; 1962.
- 21 Foster BJ, Shults J, Zemel BS, et al. Interactions between growth and body composition in children treated with high-dose chronic glucocorticoids. Am J Clin Nutr. 2004; 80: 1334–1341.
- 22 Ellis KJ, Shypailo RJ, Abrams SA, et al. The reference child and adolescent models of body composition. A contemporary comparison. Ann N Y Acad Sci. 2000; 904: 374–382.
- 23 Ellis KJ. Body composition of a young, multiethnic, male population. Am J Clin Nutr. 1997; 66: 1323–1331.
- 24 Ellis KJ, Abrams SA, Wong WW. Body composition reference data for a young multiethnic female population. Appl Radiat Isot. 1998; 49: 587–588.
- 25 Goulding A, Taylor RW, Gold E, et al. Regional body fat distribution in relation to pubertal stage: a dual-energy X-ray absorptiometry study of New Zealand girls and young women. Am J Clin Nutr. 1996; 64: 546–551.
- 26 Ogle GD, Allen JR, Humphries IR, et al. Body-composition assessment by dual-energy x-ray absorptiometry in subjects aged 4-26 y. Am J Clin Nutr. 1995; 61: 746–753.
- 27 Lloyd T, Chinchilli VM, Eggli DF, et al. Body composition development of adolescent white females: the Penn State Young Women's Health Study. Arch Pediatr Adolesc Med. 1998; 152: 998–1002.
- 28 Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002; 109: 45–60.
- 29 Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr. 1990; 44: 45–60.
- 30 Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am. 1999; 28: 255–281.
- 31 Schutte JE, Townsend EJ, Hugg J, et al. Density of lean body mass is greater in blacks than in whites. J Appl Physiol Resp Environ Exerc Physiol. 1984; 56: 1647–1649.
- 32 Sentongo TA, Semeao EJ, Piccoli DA, et al. Growth, body composition, and nutritional status in children and adolescents with Crohn's disease. J Pediatr Gastroenterol Nutr. 2000; 31: 33–40.
- 33 Ma K, Mallidis C, Bhasin S, et al. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endocrinol Metab. 2003; 285: E363–371.
- 34 Dimitriadis G, Leighton B, Parry-Billings M, et al. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J. 1997; 321(Pt 3): 707–712.
- 35 Clowes GH Jr, George BC, Villee CA Jr, et al. Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. 1983. Nutrition. 1995; 11: 775; discussion 774, 776–777.
- 36 Guttridge DC, Mayo MW, Madrid LV, et al. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science. 2000; 289: 2363–2366.
- 37 Fan J, Char D, Bagby GJ, et al. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. Am J Physiol. 1995; 269: R1204–1212.
- 38 Tirapegui J. Effect of insulin-like growth factor-1 (IGF-1) on muscle and bone growth in experimental models. Int J Food Sci Nutr. 1999; 50: 231–236.
- 39 Kirschner BS, Sutton MM. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology. 1986; 91: 830–836.
- 40 Corkins MR, Gohil AD, Fitzgerald JF. The insulin-like growth factor axis in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2003; 36: 228–234.
- 41 Thomas AG, Holly JM, Taylor F, et al. Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease. Gut. 1993; 34: 944–947.
- 42 Plevy SE, Landers CJ, Prehn J, et al. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol. 1997; 159: 6276–6282.
- 43 Sylvester FA, Davis PM, Wyzga N, et al. Are activated T cells regulators of bone metabolism in children with Crohn disease? J Pediatr. 2006; 148: 461–466.
- 44 Markowitz J, Grancher K, Rosa J, et al. Growth failure in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1993; 16: 373–380.
- 45 Griffiths A, Nguyen P, Smith C, et al. Growth and clinical course of children with Crohn's disease. Gut. 1993; 34: 939–943.
- 46 Wolfe RR. The underappreciated role of muscle in health and disease. Am J Clin Nutr. 2006; 84: 475–482.
- 47 Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr. 2006; 83: 735–743.
- 48 Parfitt AM. The two faces of growth: benefits and risks to bone integrity. Osteoporos Int. 1994; 4: 382–398.
- 49 Semeao EJ, Stallings VA, Peck SN, et al. Vertebral compression fractures in pediatric patients with Crohn's disease. Gastroenterology. 1997; 112: 1710–1713.
- 50 Sylvester FA. Cracking the risk of fractures in Crohn disease. J Pediatr Gastroenterol Nutr. 2004; 38: 113–114.